From October 06 to 08, Seppic has been taking part in CPHI Milan 2026 to reaffirm its position as a key partner in pharmaceutical formulation. This year, Seppic teams welcomed industry peers and clients at the booth to showcase our latest innovations across three key strategic areas: Dermopharmacy, Injectables, and Oral Pharma.
Here is a summary of what has been presented and demonstrated on our booth:
Dermopharmacy: Sensory exploration
In dermopharmacy, technical performance goes hand in hand with sensory experience.
For CPHI 2026 edition, Seppic offered two interactive features directly on the stand:
- The Formulation zone: a hands-on space where visitors can test the unique sensory attributes of our SEPINEO™ polymer range, from light quick-break textures to rich, comforting feels.
- Daily In-person demos: every day, our experts PharmD Alice Daneshvar and PharmD Benjamin Gavinet made on-booth demonstrations, formulating a cream-gel with high oil and solvent content using a cold process method. This showcase highlights how Seppic solutions optimize manufacturing while reducing energy use.
Injectables: Supporting biologics stability with the launch of MONTANOX™ 80 HPB
To support laboratories navigating the complex stability demands of the expanding biologics market, Seppic presents MONTANOX™ HPB range and promotes a new launch in our parenteral surfactant offering:
- The MONTANOX™ HPB range: high-purity surfactants designed to stabilize sensitive biologicals. Manufactured under GMP Part II standards with multicompendial compliance (EP, USP-NF, JP, ChP), they help our clients simplify global regulatory approvals.
- Focus on the new launch MONTANOX™ 80 HPB: Seppic is officially introducing this highly purified polysorbate 80 which prevents protein aggregation and particle formation, securing long-term active stability right from early development.
Oral Pharma: Showcasing our modern excipients & film-coatings
Seppic highlighted its problem-solving solutions for modern oral dosage forms, featuring SEPIFILM™, SEPISPERSE™, SEPITRAP™, and SEPISTAB™ ST 200.
